Taking a Shot at HPV: How vaccinating against Human Papillomavirus saves lives
Cancer touches everyone. But, an important tool in the fight against several cancers – particularly cervical cancer – is being woefully underused. That tool is the Human Papillomavirus (HPV) vaccine. In fact, less than half of the target population ever received this life-saving vaccine.
The Centers for Disease Control (CDC) reports that over a four-year period, strains of HPV were associated with about 33,200 cancers in the United
States. HPV is thought to be responsible for more than 90 percent of anal and cervical cancers, approximately 70 percent of vaginal and vulvar cancers, more than 60 percent of penile cancers and about 50 percent of head and neck cancers. The virus responsible for these cancers is so prevalent that most women and men will contract at least one strain of the virus at some point in their lives. But most are not vaccinated.
In order to best protect children from HPV related cancers, the CDC recommends that both boys and girls between the ages of nine and 21 are given the vaccine. Immunization against HPV is recommended for before a child becomes sexually active since that is the most common way for HPV infection.
“Getting the vaccine before a child is infected prevents the initial infection that subsequently will lead to cancers,” says Dr. Tom Murwin, pediatrician at Dean Clinic – Stoughton. “Once you are infected with the human papillomavirus, the vaccine doesn’t do anything. So it is important to get the vaccine before infection happens. If a female gets all three doses before she is infected with the virus, her lifetime risk of cervical – and other vaginal or vulvar – cancers is reduced by 80 percent. This also means 80 percent fewer abnormal Pap smears, 80 percent fewer follow-up doctor appointments and 80 percent fewer procedures to stop pre-cancers from becoming invasive cancers.”
The vaccination process itself is not unlike many other childhood vaccinations. Both boys and girls can receive the vaccination as early as age nine. In total, three doses of the vaccine will be administered by your doctor’s office over a six-month period. Part of the reasoning behind early vaccination against HPV is that it will allow a young person’s body to build up proper immunity to the virus before sexual activity could put them at risk for contracting a strain of HPV. The development of such a powerful cancer prevention tool should make parents take notice, says Dr. Murwin.
“For the first time in the history of medicine, we now have an incredibly safe vaccine that can prevent 80 percent of cervical cancer with three injections,” he says. “The earlier the vaccine is given, the more likely it is to be effective in preventing those cancers. It’s a real medical breakthrough.”
Some parents and family values groups voice concerns that vaccinating against a virus that is generally considered a sexually transmitted infection will lead to earlier sexual activity. Research shows this common misconception is simply not true. Others are worried about potential side effects. According to studies of the HPV vaccine, the biggest side effect is pain at the site of the vaccination. Because of this pain, some people may faint. Since the vaccine was first made available in 2006, there have been no reports of serious side effects like ovarian failure, death, stroke or other negative effects scientifically linked to the vaccine. While claims of these side effects have been publicized in the media, investigations into these claims have found them to be scientifically unfounded.
Dr. Murwin stresses to parents that avoiding or delaying the HPV vaccine increases their child’s risk of developing an HPV-associated cancer.
“HPV vaccine is an anti-cancer vaccine. We all get exposed to HPV,” he says. “If you wait and your child or teen is infected, they have lost the chance to reduce their cancer risk.
Knowing that the vaccine is safe and effective is a big message many doctors, including Dr. Murwin, hope parents and young adults take to heart.
“I have given the vaccine to my children and hope others do as well,” says Dr. Murwin. “Let me illustrate the potential benefits of human papillomavirus vaccination among girls currently 12 years or younger in the United States: If we gave it to every 12-year-old girl over the next few years and we raised vaccine coverage of young girls to 80 percent, we could avoid 53,300 lifetime cervical cancer cases over the lives of those 12-year-old girls.”